News

new PCP and PPI calls are launched

Published on | 11 months ago

Programmes
EIT

The European Commission wants contracting authorities to take up a more R&D intensive approach and contribute to the take-up of innovative products. To this purpose they have set-up a large initiative on Pre-commercial Procurement (PCP) and Public Procurement of Innovation (PPI). Some of these calls are launched within the Horizon Europe Framework. More information can be found on this infosheet. For those who are interested which calls will open in 2026 and 2027, these are the topics:

PCP Actions

  • HORIZON-INFRA-2026-TECH-01-01: R&D for the next generation of scientific instrumentation, tools, methods, digitalisation and solutions for research infrastructure upgrades. Note: this is a Research and innovation action with the clause: The specific conditions for actions with PCP/PPI procurements apply…. Proposals may include PCP102 subcontracting activities as described in part H of the General Annexes of the work programme (opens on 10 March 2026, closes on 16 June 2026)
  • HORIZON-CL3-2026-01-SSRI-02: Demand-led innovation in security (Opens on 6 May 2026, closes on 5 Nov 2026)
  • HORIZON-CL3-2027-01-SSRI-03: Demand-led innovation in security (Opens on 5 May 2027, closes on 4 Nov 2027)
  • HORIZON-CL5-2026-11-D3-04: De-risking renewable fuel technologies through transnational pre-commercial procurement of renewable fuel industrial value chains (opens on 4 August 2026, closes on 1 December 2026)
  • HORIZON-HLTH-2027-01-ENVHLTHMISSCLIMA-03: Tools and technologies to support health adaptation to climate change, (opens on 10 February 2027, deadline 13 April 2027)
  • HORIZON-MISS-2027-02-CANCER-05: Precommercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines (Opens on 10 Feb 2027, closes on 21 Sep 2027)
  • HORIZON-MISS-2027-04-CIT-05: Boosting the transformation towards climateneutral cities, the net-zero economy and open strategic autonomy through Pre-Commercial Procurement (PCP) (opens on 9 Feb 2027, closes on 7 Oct 2027)
  • HORIZON-EIE-2027-01-CONNECT-02: Reinforcing synergies between experimentation spaces and innovation procurement (opens on 1 June 2027, closes on 15 September 2027)
  • HORIZON-MISS-2027-04-CIT-05: Boosting the transformation towards climateneutral cities, the net-zero economy and open strategic autonomy through Pre-Commercial Procurement (PCP) (opens on 9 Feb 2027, closes on 7 Oct 2027)

PPI Actions

  • HORIZON-CL3-2026-01-SSRI-03: Public procurement of innovation for security (Opens on 6 May 2026, closes on 5 Nov 2026)
  • Access to integrated care: HORIZON-HLTH-2027-01-CARE-01; (opening date TBC, deadline on 13 April 2027)

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1871 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.